CCM
ELV icon

Catapult Capital Management’s Elevance Health ELV Stock Holding History

Catapult Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-60,000
Closed -$9.85M – 170
2015
Q2 		$9.85M Buy
+60,000
New +$9.59M 1.42% 13
2015
Q1 		– Sell
-53,800
Closed -$6.76M – 225
2014
Q4 		$6.76M Buy
53,800
+3,800
+8% +$470K 1.72% 16
2014
Q3 		$5.98M Buy
+50,000
New +$5.73M 0.64% 57

Other funds holding ELV

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Catapult Capital Management's ELV Position: Q3 2015 in Review

Catapult Capital Management sold out of Elevance Health (ELV) in Q3 2015, closing a stake of 60,000 shares — an estimated $9.85M sold.

Catapult Capital Management first reported a position in ELV in Q3 2014 and held it in 3 quarters. The position peaked at $9.85M in Q2 2015. 761 funds tracked by Wall St. Rank hold ELV as of Q3 2015.

  • Catapult Capital Management reported no remaining Elevance Health position as of Q3 2015 after selling out during the quarter.
  • Catapult Capital Management sold 60,000 Elevance Health shares in Q3 2015, an estimated $9.85M.
  • Catapult Capital Management first reported a position in Elevance Health in Q3 2014 and held it in 3 quarters.
  • Catapult Capital Management's Elevance Health position peaked at $9.85M in Q2 2015.
  • 761 funds tracked by Wall St. Rank held Elevance Health as of Q3 2015.

Based on Catapult Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.